tiprankstipranks
Mereo Biopharma (MREO)
:MREO
US Market

Mereo Biopharma Group Plc (MREO) Financial Statements

Compare
602 Followers

Mereo Biopharma Group Plc Financial Overview

Mereo Biopharma Group Plc's market cap is currently $349.08M. The company's EPS TTM is $-0.293; its P/E ratio is ―; Mereo Biopharma Group Plc is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is
gt;-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 10.00M$ 1.51M$ 36.46M$ 393.00K
Gross Profit$ 0.00$ 7.43M$ 571.00K$ 18.56M$ -15.95M
Operating Income$ -47.36M$ -28.42M$ -43.57M$ -20.94M$ -37.57M
EBITDA$ -47.36M$ -26.06M$ -42.06M$ -5.00M$ -37.52M
Net Income$ -43.25M$ -29.47M$ -34.20M$ 12.72M$ -163.63M
Balance Sheet
Cash & Short-Term Investments$ 69.80M$ 57.42M$ 56.33M$ 94.30M$ 23.47M
Total Assets$ 76.39M$ 66.50M$ 88.08M$ 126.42M$ 62.95M
Total Debt$ 894.00K$ 5.95M$ 12.77M$ 16.76M$ 17.94M
Net Debt$ -68.91M$ -51.47M$ -43.56M$ -77.54M$ -5.53M
Total Liabilities$ 15.42M$ 15.96M$ 26.21M$ 38.41M$ 77.92M
Stockholders' Equity$ 60.97M$ 50.54M$ 61.87M$ 88.00M$ -14.97M
Cash Flow
Free Cash Flow$ -32.83M$ -21.55M$ -38.83M$ -5.77M$ -28.36M
Operating Cash Flow$ -32.83M$ -21.13M$ -38.82M$ -5.24M$ -28.34M
Investing Cash Flow$ -699.00K$ -419.00K$ 1.50M$ -421.00K$ 1.50M
Financing Cash Flow$ 46.15M$ 7.97M$ -784.00K$ 77.65M$ 34.74M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History

Mereo Biopharma Group Plc Debt to Assets

Mereo Biopharma Group Plc Cash Flow

Mereo Biopharma Group Plc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis